Risk Reductions across Hypoglycemia Definitions with Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in SWITCH 1 and 2

Carol Wysham; Janusz Gumprecht; Wendy Lane; Lone N?rg?rd Troelsen; Deniz Tutkunkardas; Jina Hahn; Simon Heller

首页> 外文期刊>Canadian journal of diabetes >Risk Reductions across Hypoglycemia Definitions with Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in SWITCH 1 and 2

【24h】

Risk Reductions across Hypoglycemia Definitions with Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in SWITCH 1 and 2

机译：用胰岛素Degludec（IDEG）与胰岛素冰柱U100（Iglar）的低血糖定义对开关1和2中的胰岛素冰柱U100（IGLAR）的风险降低

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Canadian journal of diabetes 》 |2017年第speca期| 共2页
作者
Carol Wysham; Janusz Gumprecht; Wendy Lane; Lone N?rg?rd Troelsen; Deniz Tutkunkardas; Jina Hahn; Simon Heller;
展开▼
作者单位

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Risk Reductions across Hypoglycemia Definitions with Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in SWITCH 1 and 2 [J] . Carol Wysham, Janusz Gumprecht, Wendy Lane, Canadian journal of diabetes . 2017 ,第Speca期

机译：用胰岛素Degludec（IDEG）与胰岛素冰柱U100（Iglar）的低血糖定义对开关1和2中的胰岛素冰柱U100（IGLAR）的风险降低
2. Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial [J] . Louis Chaykin, Anuj Bhargava, Raymond de la Rosa, Clinical diabetes . 2019 ,第1期

机译：胰岛素Degludec与胰岛素冰柱U100对2型糖尿病患者低血基血症的影响：开关2试验结果
3. Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes The SWITCH 2 Randomized Clinical Trial [J] . Wysham Carol, Bhargava Anuj, Chaykin Louis, JAMA: the Journal of the American Medical Association . 2017 ,第1期

机译：胰岛素Degludec vs胰岛素Glargine U100对2型糖尿病患者的低血基血症开关2随机临床试验
4. Insulin Degludec, Insulin Glargine U300, and Other Novel Insulin Formulations [C] . American College of Veterinary Internal Medicine Forum Conference . 2018

机译：胰岛素Degludec，胰岛素甘氨酸U300等新型胰岛素配方
5. Incidence of hypoglycemia and associated costs in Type 1and Type 2 diabetes patients treated with insulin analogs vs. human insulin: A retrospective cohort study. [D] . Shah, Hiren P. 2014

机译：使用胰岛素类似物与人胰岛素治疗的1型和2型糖尿病患者的低血糖发生率和相关费用：一项回顾性队列研究。
6. Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes [O] . Anastasios Tentolouris, Ioanna Eleftheriadou, Nikolaos Tentolouris 2018

机译：与甘精胰岛素U100相比地格曲胰岛素U100与1型糖尿病患者发生严重和症状性低血糖的风险较低
7. Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial [O] . Louis Chaykin, Anuj Bhargava, Raymond de la Rosa, 2018

机译：胰岛素Degludec与胰岛素冰柱U100对2型糖尿病患者低血基血症的影响：开关2试验结果

Risk Reductions across Hypoglycemia Definitions with Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in SWITCH 1 and 2

著录项

相似文献

相关主题

期刊订阅